ADVANTAGE® Prosthetic Heart Valve Long-term Follow-up Trial

NCT01264484 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 212

Last updated 2017-03-30

No results posted yet for this study

Summary

The objective of this study is to assess long term safety and durability of the Advantage prosthetic heart valve.

Conditions

  • Heart Valve Stenosis

Interventions

DEVICE

Advantage Prosthetic Heart Valve

All patients eligible for this study are treated with an Advantage prosthetic heart valve

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • Rudiger Lange, Prof. Dr. · Deutsches Herzzentrum München

  • Jan Gummert, prof. dr. · Herzzentrum Nordrhein-Westfalen, Bad Oeynhausen

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2015-12-31
Completion
2016-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01264484 on ClinicalTrials.gov